Bharat Biotech's Covaxin approved for phase 2/3 trials on children

The DGCI has approved Bharat Biotech's COVID-19 vaccine Covaxin for phase II/III clinical trial on those aged between two to 18 years.

from IndiaTV: Google News Feed https://ift.tt/3tGl4xd